Delivery Order SPE2DB22D3301-SPE2DB24FX9DP
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply TOPIRAMATE ER 100 MG CAPSULES 30S for a potential value of $4,833.86. The contract has a completion date of January 29, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order and has previously received numerous federal contract awards from DLA Troop Support Medical to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TOPIRAMATE ER 150 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $3,998.38 and a performance period that ends on March 12, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,703.98, is for the delivery of 4567221494 - TOPIRAMATE ER 100 MG CAPSULE 30S. It is a Firm Fixed Price Delivery Order contract with a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,136,599 units of TOPIRAMATE ER 100 MG CAPSULE 100S. The $5,825.60 delivery order has a completion date of December 20, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received multiple contracts from DLA to supply pharmaceuticals, medical supplies, and related distribution services to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide TOPIRAMATE ER 200 MG CAPSULE 30S. The contract has a potential value of $6,111.95 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order contract is issued under a larger indefinite delivery contract (IDC) awarded...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563416640 - TOPIRAMATE ER 200 MG CAPSULE 30S. The contract has a completion date of January 24, 2024 and a potential value of $3,586.38. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceutical products...
- This contract award is for the delivery of TOPIRAMATE ER 100 MG CAPSULE 30S, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The $23,102.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 15, 2024. The contract has an ultimate completion date of August 16, 2024 and does not utilize a set-aside designation. Amerisourcebergen is the prime contractor for this award, which is associated with a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TOPIRAMATE ER 100 MG CAPSULE 30S. The potential value of this award is $6,631.97 with a completion date of February 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor on this delivery order. The contract does not have a...
- This federal contract award, valued at $6,899.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOPIRAMATE ER 100 MG CAPSULE 30S, a pharmaceutical product, with a completion date of November 13, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $7,810.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOPIRAMATE ER 100 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 8, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX9DPDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TOPIRAMATE ER 100 MG CAPSULE 30S, a pharmaceutical product. The potential value of the contract is $4,217.16, with a completion date of January 23, 2024. This order was not set aside for any specific business type. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and medical supplies to support U.S. government agencies, primarily the Department of Defense. The company has previously received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services for military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 1/22/24 |